OncLive | Bringing the Global Oncology Community Together

Long-term maintenance therapy with olaparib (Lynparza) tablets demonstrated a low rate of treatment discontinuation and tolerable safety profile in patients with platinum-sensitive recurrent ovarian cancer. Read More >>

Expert Explains Surgical Considerations in High-Risk Prostate Cancer

Enhanced Education Part of Successful Biosimilar Integration

NY LUNG 2018: More Data Needed on Changing Systemic Therapy in NSCLC

NY LUNG 2018: Biomarkers and Histology Play Key Roles in Frontline Metastatic NSCLC Options

FDA Grants Atezolizumab Combo Priority Review for Frontline TNBC

View More Stories >>

View Conference Coverage

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

Dr. Nguyen on Treatment Approaches for Patients With Advanced Ovarian Cancer

Dr. Feldman on the Future of Durvalumab and Tremilimumab in NSCLC

Dr. Rugo on Resistance to CDK4/6 Inhibitors in HR+ Breast Cancer

Dr. Powles on Biomarkers for Immunotherapy in Bladder Cancer

Dr. Lassen Discusses TRK Fusions in Pediatric Patients

Dr. Gorantla on the Impact of the APHINITY Trial in HER2+ Breast Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Additional Targets in NSCLC: BRAF V600E and BRAF Variants

Second Generation ALK Inhibitors in NSCLC

Practice-Changing Frontline Treatment of ALK+ NSCLC

Updates in the Treatment of ALK+ and ROS1+ NSCLC

Adjuvant TKI for Early Stage EGFR+ NSCLC

Frontline Chemo and TKI Combination in EGFR+ NSCLC

Promising EGFR Inhibitors in Development for NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Management of Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

BEACON Trial: Triplet Therapy in BRAF V600E

Later Lines of Therapy for Metastatic Colorectal Cancer

Other I-O Approaches to Metastatic Colorectal Cancer

ReDOS Trial: Optimizing Regorafenib Dosing in metastatic Colorectal Cancer

I-O Therapy in mCRC: Ipilimumab + Nivolumab

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>